Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis

por Zhang, Juan, Xu, Dong-Ling, Liu, Xiao-Bo, Bi, Shao-jie, Zhao, Tong, Sui, Shu-Jian, Ji, Xiao-Ping, Lu, Qing-Hua
Publicado 2016